The Evolution of SEND at AstraZeneca

被引：0
|
作者：
Kent, Claire [1 ]
Coupland, Brett [1 ]
Barnard, Claire [2 ]
Schofield, Jason [3 ]
Afif-Rider, Shameen [4 ]
机构：
[1] AstraZeneca, Clin Pharmacol Safety Sci, Regulatory Safety, R&D, Cambridge, England
[2] AstraZeneca, Clin Pharmacol Safety Sci, Regulatory Safety, R&D, Alderley Pk, England
[3] AstraZeneca, Clin Pharmacol & Safety Sci, Data Sci & AI, R&D, Cambridge, England
[4] AstraZeneca, Clin Pharmacol & Safety Sci, Regulatory Safety, R&D, Gaithersburg, MD USA
来源：
REGULATORY TOXICOLOGY AND PHARMACOLOGY | 2021年 / 123卷
关键词：
SEND; CDISC; SDTM; US FDA; Submission; Toxicology; Data warehousing; Analytics;
D O I：
10.1016/j.yrtph.2021.104954
中图分类号：
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号：
0301 ; 10 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
12345